Rob Dillard

DocwireNews

A novel technology based on nanosensors may be able to effectively diagnose lung cancer, according to a study <a href="https://www.science.org/doi/10.1126/sciadv.adj9591" target="_blank" rel="noopener">published</a> in Science Advances.The nanosensors are delivered via an inhaler or nebulizer. If the sensors encounter cancer-linked proteins in the lungs, they produce a signal that accumulates in the urine, where it can be detected with a simple paper test strip. The investigators noted that the sensors consist of polymer nanoparticles coated with a reporter, which acts as a DNA barcode and is cleaved from the particle when the sensor encounters enzymes called proteases. These enzymes are usually overactive in tumors.This novel approach could potentially replace or supplement the current gold standard for diagnosing lung cancer, low-dose computed tomography (CT). It could also have a notable impact in low- and middle-income countries where CT scanners are not widely available, the researchers noted, and provide a dramatic improvement in lung cancer screening.&ldquo;Around the world, cancer is going to become more and more prevalent in low- and middle-income countries. The epidemiology of lung cancer globally is that it&rsquo;s driven by pollution and smoking, so we know that those are settings where accessibility to this kind of technology could have a big impact,&rdquo; said Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science at MIT and a member of MIT&rsquo;s Koch Institute for Integrative Cancer Research and the Institute for Medical Engineering and Science, via a <a href="https://www.eurekalert.org/news-releases/1030320" target="_blank" rel="noopener">press release.</a>The researchers assessed the diagnostic system in a mouse model, which was given to mice who developed lung tumors similar to those seen in humans. The sensors were administered 7.5 weeks after the tumors started to form, a time point that would likely correlate with stage I or II cancer in humans.In their first set of experiments in the mice, the researchers measured the levels of 20 different sensors designed to detect different proteases. Researchers used a machine learning algorithm to analyze the results and found that a combination of just 4 sensors yielded diagnostic results. When used in combination with the mouse model, the researchers found that it could accurately detect early-stage lung tumors.&ldquo;The idea would be you come in and then you get an answer about whether you need a follow-up test or not, and we could get patients who have early lesions into the system so that they could get curative surgery or lifesaving medicines,&rdquo; Prof. Bhatia said.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Inhalable Nanosensor Technology Could Enable Early Lung Cancer Detection

Lung Cancer

A novel technology based on nanosensors may be able to effectively detect early-stage lung tumors.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe